Oramed Pharmaceuticals Inc. – Filings and Transcripts

NASDAQ: ORMP
Share price (9/30/26): $4.67
Market cap (9/30/26): $194 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

Late quarterly filing notification for Q1 2026

ended 12/31/25 FY 2025

ended 09/30/25 Q3

Prospectuses and Registrations Filter

Registration of securities on exchange

Registration of securities for employees

Prospectus supplement for primary offering

Registration of securities for employees

Prospectus supplement for primary offering

Ownership Filter

Aquamarine Financial (Cayman) Ltd

News Filter

Shareholder Vote Results

Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Other Events, Financial Statements or Exhibits

Material Definitive Agreement, Completion of Acquisition or Disposition of Assets

Material Definitive Agreement, Financial Statements or Exhibits

Oramed and Lifeward Announce Strategic Transaction

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Definitive proxy

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness